Hydroxyzine Hydrochloride
NDC 0121-1034, hydroxyzine hydrochloride, solution, from PAI Holdings, LLC dba PAI Pharma.
- Product NDC
- 0121-1034
- Status
- Listed
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA040391
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0121-1034 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYDROXYZINE DIHYDROCHLORIDE10 mg/5mL
Pharmacologic classes
Antihistamine [EPC]; Histamine Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0121-1034-16 | 00121103416 | 473 mL in 1 BOTTLE (0121-1034-16) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2a343906-0bea-4bd8-bd35-c3f199d9b266NADAC price for package 00121103416
GET /v1/drugs/nadac/00121103416
Use it
Look up 0121-1034 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0121-1034 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0121-1034. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.